Visit the Diopsys booth at SECO 2021!
Objective, functional results for you. Enhanced care for your patients.
Diopsys, Inc. provides innovative technology to help improve your clinical practice. We have made unprecedented progress in the field of visual electrophysiology, creating accessible, practical electroretinography (ERG) and visual evoked potential (VEP) vision tests that can benefit your daily patients. Results from these tests are clinically effective in helping to manage a variety of vision disorders such as
diabetic retinopathy,
CRVO,
retinal concerns obscured by media opacities,
uveitis,
optic neuritis,
vision problems due to TBI, and more.
1-7
Please visit us at booth #643 to learn how modern ERG and VEP can benefit your diagnostic and treatment plans.
- Both objective and functional test results
- Enhanced treatment tracking and disease management
- Intuitive, color-coded reports based on documented reference ranges
This is visual electrophysiology for the 21st century. Come see for yourself.
Yasuda S, et al. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmol. 2015;93:e465-8. 2. Moschos MM, et al. Electrophysiological examination in uveitis: a review of the literature. Clin Ophthalmol. 2014;8:199-214. 3. Larsson J, Andréasson S. Photopic 30 Hz flicker ERG as a predictor for Rubeosis in central retinal vein occlusion. Br J Ophthalmol. 2001;85:683-5. 4. Ratanapakorn T, et al. Effect of cataract on electroretinographic response. J Med Assoc Thai. 2010 Oct;93(10):1196-9. 5. Holm K, et al. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular edema. Doc Ophthalmol. 2015;131:43-51. 6. Naismith et al. Optical coherence tomography Is less sensitive than visual evoked potentials in optic neuritis. Neurology. 2009 Jul 7;73(1):46-52. 7. McKerral et al. Visual and Cognitive Information Processing after Traumatic Brain Injury: VEP and ERP Studies. Invest Ophthalmol Vis Sci 2002;43: E-Abstract 1803.
